A real-world evidence study of interhospital variability in the surgical treatment of patients with benign prostatic hyperplasia: the REVALURO study.

Autor: Iván PM; Consorcio Hospital General Universitario, Av. de les Tres Creus, 2, Valencia, Spain., Alberto BA; Hospital Universitario y Politécnico La Fe, Av. de Fernando Abril Martorell, 106, Valencia, Spain., Lluís PC; Hospital Clínic de Barcelona, C. de Villarroel, 170, Barcelona, Spain., Maurizio D; Hospital Clínic de Barcelona, C. de Villarroel, 170, Barcelona, Spain., Jose Luís GB; Hospital Universitario Marqués de Valdecilla, Av. De Valdecilla, Santander, Spain., Francisco Javier VP; Hospital Universitario Virgen de las Nieves, Av. De las Fuerzas Armadas, 2, Granada, Spain., Almudena SB; Hospital Universitario Virgen de las Nieves, Av. De las Fuerzas Armadas, 2, Granada, Spain., Jaime GH; Hospital Universitario Marqués de Valdecilla, Av. De Valdecilla, Santander, Spain., Esperanza TM; Health Economics and Market Access, Boston Scientific Inc., Madrid, Spain., Pablo BA; Health Economics and Market Access, Boston Scientific Inc., Madrid, Spain., Gabriela OA; Health Outcomes Performance Ecosystem for Sustainability (HOPES), Valencia, Spain., Manuel GB; Pharmacoeconomics and Outcomes Research Iberia (PORIB), Paseo Joaquín Rodrigo 4 - Letter I, Madrid, Spain., Miguel Ángel C; Pharmacoeconomics and Outcomes Research Iberia (PORIB), Paseo Joaquín Rodrigo 4 - Letter I, Madrid, Spain., Alberto CG; Pharmacoeconomics and Outcomes Research Iberia (PORIB), Paseo Joaquín Rodrigo 4 - Letter I, Madrid, Spain. adelacuadra@porib.com., Emilio LA; Consorcio Hospital General Universitario, Av. de les Tres Creus, 2, Valencia, Spain.

Publikováno v: International urology and nephrology [Int Urol Nephrol] 2024 Oct 29. Date of Electronic Publication: 2024 Oct 29.